Closing Bell: Fennec Pharmaceuticals Inc up on Monday (FRX)

In today's trading, Fennec Pharmaceuticals Inc shares closed at $9.02 after opening the day at $8.86. Intraday prices ranged from a low of $8.65 to a high of $9.27.

The price advanced 2.04 percent from the previous day's close of $8.84.

During the day across North America, the TSX Composite closed -0.26% at 22813.75, the S&P 500 closed 1.08% at 5564.41, the Dow Jones Industrial Average closed 0.32% at 40415.44 and the Nasdaq Composite closed 1.58% at 18007.57.

Fennec Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker FRX.

A total of 3,600 shares was traded during the last trading day, with total trades of 35, with an average volume of 1,380 over 5 days.

The TSX market on the whole today saw 3,093 price advancers against 2,137 declines and 96 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, in the last 12 months, Fennec Pharmaceuticals Inc's shares have dipped -19.96%, while in 2024, they have shrunken -40.50%.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $246.44 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.

Fennec Pharmaceuticals Inc is a None company headquartered in Research Triangle Park, USA.

Based on 6.00 analysts, Fennec Pharmaceuticals Inc gets an average recommendation of "Strong Buy" according to Zacks. From those 6 analysts, 6 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..